13F HOLDINGS REPORT
ACUTA CAPITAL PARTNERS, LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001104659-23-117779
Total Value
$149.2M
Positions
46
Other Managers
0
Confidential Omitted
No
Holdings (46)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TAYSHA GENE THERAPIES INC | TSHA | 3,827,926 | $12.1M | 8.11% |
| 2 | APELLIS PHARMACEUTICALS INC | APLS | 244,484 | $9.3M | 6.23% |
| 3 | AADI BIOSCIENCES INC | WHWK | 1,849,402 | $9.0M | 6.00% |
| 4 | PRAXIS PRECISION MEDICINES I | PRAX | 4,485,000 | $7.7M | 5.14% |
| 5 | RAYZEBIO INC | 75525N107 | 344,571 | $7.6M | 5.13% |
| 6 | SAREPTA THERAPEUTICS INC | SRPT | 550 | $7.6M | 5.08% |
| 7 | ROCKET PHARMACEUTICALS INC | RCKTW | 362,000 | $7.4M | 4.97% |
| 8 | VENTYX BIOSCIENCES INC | 92332V107 | 205,377 | $7.1M | 4.78% |
| 9 | DISC MEDICINE INC | IRON | 138,198 | $6.5M | 4.35% |
| 10 | KURA ONCOLOGY INC. | KURA | 702,093 | $6.4M | 4.29% |
| 11 | CYMABAY THERAPEUTICS INC | 23257D103 | 418,000 | $6.2M | 4.18% |
| 12 | VAXCYTE INC | PCVX | 121,022 | $6.2M | 4.13% |
| 13 | IMMUNOVANT INC | IMVT | 129,000 | $5.0M | 3.32% |
| 14 | SYNDAX PHARMACEUTICALS INC | SNDX | 297,035 | $4.3M | 2.89% |
| 15 | HILLEVAX INC | 43157M102 | 270,319 | $3.6M | 2.44% |
| 16 | ALKERMES PLC | ALKS | 126,500 | $3.5M | 2.37% |
| 17 | VIRIDIAN THERAPEUTICS INC | VRDN | 224,339 | $3.4M | 2.31% |
| 18 | CELLDEX THERAPEUTICS INC | CLDX | 122,341 | $3.4M | 2.26% |
| 19 | CRINETICS PHARMACEUTICALS INC | CRNX | 94,000 | $2.8M | 1.87% |
| 20 | TERNS PHARMACEUTICALS INC | TERN | 555,260 | $2.8M | 1.87% |
| 21 | REPLIMUNE GROUP INC | REPL | 150,000 | $2.6M | 1.72% |
| 22 | EYEPOINT PHARMACEUTICALS INC | EYPT | 300,128 | $2.4M | 1.61% |
| 23 | IKENA ONCOLOGY INC | 45175G108 | 551,010 | $2.4M | 1.60% |
| 24 | CENTESSA PHARMACEUTICALS PLC | CNTA | 323,349 | $2.1M | 1.40% |
| 25 | OLEMA PHARMACEUTICALS INC | OLMA | 153,007 | $1.9M | 1.27% |
| 26 | SAREPTA THERAPEUTICS INC | SRPT | 15,500 | $1.9M | 1.26% |
| 27 | VERASTEM INC | VSTM | 230,000 | $1.9M | 1.25% |
| 28 | REPLIMUNE GROUP INC | REPL | 1,000 | $1.8M | 1.18% |
| 29 | 89BIO INC | 282559103 | 1,000 | $1.5M | 1.02% |
| 30 | ENLIVEN THERAPEUTICS INC | ELVN | 103,600 | $1.4M | 0.95% |
| 31 | DYNE THERAPEUTICS INC | DYN | 146,500 | $1.3M | 0.88% |
| 32 | KRONOS BIO INC | 50107A104 | 718,739 | $934,361 | 0.63% |
| 33 | ACLARIS THERAPEUTICS | ACRS | 121,692 | $833,590 | 0.56% |
| 34 | BRAINSTORM CELL THERAPEUTICS | BCLI | 2,500 | $825,000 | 0.55% |
| 35 | BIOMEA FUSION INC | BMEA | 39,935 | $549,506 | 0.37% |
| 36 | IONIS PHARMACEUTICALS INC | IONS | 11,300 | $512,568 | 0.34% |
| 37 | 89BIO INC | 282559103 | 32,800 | $506,432 | 0.34% |
| 38 | LEAP THERAPEUTICS INC | CYPH | 354,166 | $488,749 | 0.33% |
| 39 | REZOLUTE INC | RZLT | 310,000 | $409,200 | 0.27% |
| 40 | CELLECTAR BIOSCIENCES INC. | CLRB | 121,300 | $320,232 | 0.21% |
| 41 | STRUCTURE THERAPEUTICS INC | GPCR | 5,000 | $252,100 | 0.17% |
| 42 | AN2 THERAPEUTICS INC | ANTX | 13,300 | $213,864 | 0.14% |
| 43 | MARINUS PHARMECEUTICALS INC | 56854Q200 | 19,500 | $156,975 | 0.11% |
| 44 | MERSANA THERAPEUTICS INC | 59045L106 | 99,607 | $126,501 | 0.08% |
| 45 | GLYCOMIMETIC INC | 38000Q102 | 27,500 | $41,250 | 0.03% |
| 46 | NUVATION BIO INC | NUVB | 90,832 | $9,083 | 0.01% |